IL10 and infection: Consistent with in vitro culture studies (see above), administration of AEA reduced the expression of several proinflammatory cytokines, increased that of IL-10 in serum at 90 days post infection (dpi), and improved motor function in a demyelinating disease model induced by TMEV (94).